Showing results (21-30 of 23,903) with videos related to

Sort By:
Pageof 2,391
Neuro-Oncology Advances|July 18, 2024
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapyTuesday Haynes, Mark R Gilbert, Kevin Breen, et al.
Cancers|January 26, 2020
Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and ParagangliomaYang Liu, Ying Pang, Veronika Caisova, et al.
Frontiers in Endocrinology|October 7, 2021
Identification of Isocitrate Dehydrogenase 2 (IDH2) Mutation in Carotid Body ParagangliomaFengchao Lang, Abhishek Jha, Leah Meuter, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 2009
Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic gangliaNa Niu, Jie Zhang, Yong Guo, et al.
Plos One|April 3, 2014
Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in miceXu Yi, Li Long, Chunzhang Yang, et al.
Cell Reports|January 16, 2013
Proteostasis modulators prolong missense VHL protein activity and halt tumor progressionChunzhang Yang, Kristin Huntoon, Alexander Ksendzovsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Myt1 Kinase: An Emerging Cell-Cycle Regulator for Cancer TherapeuticsFengchao Lang, Karambir Kaur, Javeria Zaheer, et al.
Cancers|August 7, 2021
Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and ParagangliomaKaterina Hadrava Vanova, Chunzhang Yang, Leah Meuter, et al.
Translational Oncology|December 23, 2019
Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant GliomasYiqiang Zhou, Yang Liu, Junwen Zhang, et al.
International Journal of Medical Sciences|February 14, 2015
New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in gliomaLilia Dimitrov, Christopher S Hong, Chunzhang Yang, et al.
Pageof 2,391